Cargando…

A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer

Detalles Bibliográficos
Autores principales:	Ma, Jian, Yang, Burton B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771092/ https://www.ncbi.nlm.nih.gov/pubmed/31570102 http://dx.doi.org/10.1186/s40880-019-0397-1

Ejemplares similares

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
por: Ruan, Ji
Publicado: (2019)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer
por: Wang, Liming, et al.
Publicado: (2020)

Helicobacter pylori's road to colonization
por: Walton, Emma Louise
Publicado: (2016)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2020)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection
por: Saso, Kazuhiro, et al.
Publicado: (2019)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

Prognostic impact of mutation profiling in patients with stage II and III colon cancer
por: Shen, Yinchen, et al.
Publicado: (2016)

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
por: Diao, Feiyu, et al.
Publicado: (2019)

Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Prognostic significance of primary tumor localization in stage II and III colon cancer
por: Sakin, Abdullah, et al.
Publicado: (2018)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

NIR-II thiopyrylium dyads guided photodynamic inactivation of Coronavirus
por: Xu, Yunjie, et al.
Publicado: (2023)

Tools of the trade: plasmid repositories and standardized plasmid manipulation for molecular and synthetic biology
por: Dolan, Stephen K., et al.
Publicado: (2022)

Futility versus utility of marrow assessment in initial Ewing sarcoma staging workup
por: Anderson, Peter M
Publicado: (2015)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Seeing is believing: a novel tool for quantitating mitophagy
por: Wang, Liming, et al.
Publicado: (2020)

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
por: Yan, D-W, et al.
Publicado: (2010)

A recurrent fusion gene in high-grade endometrial stromal sarcoma: a new tool for diagnosis and therapy?
por: Ried, Thomas, et al.
Publicado: (2012)

A new bioinformatics tool to recover missing gene expression in single-cell RNA sequencing data
por: Li, Jingyi Jessica
Publicado: (2020)

Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
por: Zhu, Ning, et al.
Publicado: (2022)

New molecular tools for enhancing methane production, explaining thermodynamically limited lifestyles and other important biotechnological issues
por: Daniels, Craig, et al.
Publicado: (2009)

Metabolite labelling as a tool to define hierarchies in Clostridium acetobutylicum sugar usage and its relevance for biofuel production
por: Hidalgo, María, et al.
Publicado: (2017)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer
por: Kuroda, Kenji, et al.
Publicado: (2022)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

DSSylation, a novel guide for protein degradation?
por: Gong, Cheng-Xin
Publicado: (2014)

Mining for novel antibiotics in the age of antimicrobial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer
por: Sebio, Ana, et al.
Publicado: (2015)

Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer
por: Ma, Min, et al.
Publicado: (2019)

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
por: Sperlich, Andreas, et al.
Publicado: (2018)

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
por: Zhang, Chunze, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23fbvf6kcgnfq8auilnpdq5mah